Molecular biological characteristics of bilateral primary breast cancer
10.3781/j.issn.1000-7431.2011.11.013
- Author:
Xin-Rong ZHUANG
1
Author Information
1. Department of Breast Oncology
- Publication Type:Journal Article
- Keywords:
Bilateral;
Breast neoplasms;
Molecular biology;
Risk factors
- From:
Tumor
2011;31(11):1031-1035
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To evaluate the molecular biological characteristics of bilateral primary breast cancer (BPBC). Methods: The clinicopathological characteristics of 325 patients with BPBC and 650 patients with unilateral breast cancer (UBC) were retrospectively analyzed. The evidence of molecular biology related to the occurrence of BPBC was evaluated by univariate analysis and multivariate Logistic regression analysis. Results: The early occurrence of first primary breast cancer, a family history of breast cancer, a maximum tumor diameter of more than 5 cm, and clinical stage III were more frequent in BPBC patients than in UBC patients (P < 0.05). The negative rates of estrogen receptor (ER) and progesterone receptor (PR), the positive rate of p53, and the incidence of high expression of Ki67 were higher in BPBC patients than those in UBC patients (P < 0.05), but there was no difference in the expression of human epidermal growth factor receptor 2 (Her-2) between BPBC patients and UBC patients (P > 0.05). The characteristics including a family history of breast cancer, a maximum tumor diameter of more than 5 cm and positive expression of p53 in BPBC were independent risk factors. The patients with positive ER or positive PR had a lower risk of BPBC. Conclusion: There are differences in biological characteristics between BPBC and UBC. The breast cancer patients with the characteristics including young woman, a family history of breast cancer, negative expression of hormone receptor, positive expression of p53, and high expression of Ki67 should pay attention to the occurrence of contralateral breast cancer. Copyright© 2011 by TUMOR.
